Role of the Cdc25A Phosphatase in Human Breast Cancer

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2000 Sep 21

PMID 10995786

Citations 61

Authors

M G Cangi

B Cukor

P Soung

S Signoretti

G Moreira Jr

M Ranashinge

B Cady

M Pagano

M Loda

Affiliations

Soon will be listed here.

Abstract

The phosphatase Cdc25A plays an important role in cell cycle regulation by removing inhibitory phosphates from tyrosine and threonine residues of cyclin-dependent kinases, and it has been shown to transform diploid murine fibroblasts in cooperation with activated Ras. Here we show that Cdc25A is overexpressed in primary breast tumors and that such overexpression is correlated with higher levels of cyclin-dependent kinase 2 (Cdk2) enzymatic activity in vivo. Furthermore, in the breast cancer cell line MCF-7, Cdc25A activity is necessary for both the activation of Cdk2 and the subsequent induction of S-phase entry. Finally, in a series of small (< 1 cm) breast carcinomas, overexpression of Cdc25A was found in 47% of patients and was associated with poor survival. These data suggest that overexpression of Cdc25A contributes to the biological behavior of primary breast tumors and that both Cdc25A and Cdk2 are suitable therapeutic targets in early-stage breast cancer.

Citing Articles

Overexpression of , and Genes Could Be an Important Clue for Luminal A Breast Cancer.

Kaya M, Abuaisha A, Suer I, Alptekin M, Abanoz F, Emiroglu S Eur J Breast Health. 2024; 20(4):284-291.

PMID: 39323324 PMC: 11589183. DOI: 10.4274/ejbh.galenos.2024.2024-4-3.

Centrosomes and associated proteins in pathogenesis and treatment of breast cancer.

Athwal H, Kochiyanil A, Bhat V, Allan A, Parsyan A Front Oncol. 2024; 14:1370565.

PMID: 38606093 PMC: 11007099. DOI: 10.3389/fonc.2024.1370565.

Potential of CDC25 phosphatases in cancer research and treatment: key to precision medicine.

Dakilah I, Harb A, Abu-Gharbieh E, El-Huneidi W, Taneera J, Hamoudi R Front Pharmacol. 2024; 15:1324001.

PMID: 38313315 PMC: 10834672. DOI: 10.3389/fphar.2024.1324001.

TMED2 Induces Cisplatin Resistance in Breast Cancer via Targeting the KEAP1-Nrf2 Pathway.

Liang C, Zhang H, Wang Y, Yang L, Du Y, Luo Y Curr Med Sci. 2023; 43(5):1023-1032.

PMID: 37615927 DOI: 10.1007/s11596-023-2777-7.

Small molecule and peptide inhibitors of βTrCP and the βTrCP-NRF2 protein-protein interaction.

Jaffry U, Wells G Biochem Soc Trans. 2023; 51(3):925-936.

PMID: 37293994 PMC: 10317156. DOI: 10.1042/BST20220352.

References

Mailand N, Falck J, Lukas C, Syljuasen R, Welcker M, Bartek J . Rapid destruction of human Cdc25A in response to DNA damage. Science. 2000; 288(5470):1425-9. DOI: 10.1126/science.288.5470.1425. View

Ma Z, Chua S, Demayo F, Tsai S . Induction of mammary gland hyperplasia in transgenic mice over-expressing human Cdc25B. Oncogene. 1999; 18(32):4564-76. DOI: 10.1038/sj.onc.1202809. View

Pardee A . G1 events and regulation of cell proliferation. Science. 1989; 246(4930):603-8. DOI: 10.1126/science.2683075. View

Sadhu K, Reed S, Richardson H, Russell P . Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2. Proc Natl Acad Sci U S A. 1990; 87(13):5139-43. PMC: 54277. DOI: 10.1073/pnas.87.13.5139. View

Galaktionov K, Beach D . Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins. Cell. 1991; 67(6):1181-94. DOI: 10.1016/0092-8674(91)90294-9. View

Gabrielli B, Lee M, Walker D, Piwnica-Worms H, Maller J . Cdc25 regulates the phosphorylation and activity of the Xenopus cdk2 protein kinase complex. J Biol Chem. 1992; 267(25):18040-6. View

Gu Y, Rosenblatt J, MORGAN D . Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 1992; 11(11):3995-4005. PMC: 556910. DOI: 10.1002/j.1460-2075.1992.tb05493.x. View

Sebastian B, Kakizuka A, Hunter T . Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc Natl Acad Sci U S A. 1993; 90(8):3521-4. PMC: 46332. DOI: 10.1073/pnas.90.8.3521. View

Rosen P, Groshen S, Kinne D, Norton L . Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. J Clin Oncol. 1993; 11(11):2090-100. DOI: 10.1200/JCO.1993.11.11.2090. View

10.

Jinno S, Suto K, Nagata A, Igarashi M, Kanaoka Y, Nojima H . Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J. 1994; 13(7):1549-56. PMC: 394984. DOI: 10.1002/j.1460-2075.1994.tb06417.x. View

11.

Hoffmann I, Draetta G, Karsenti E . Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J. 1994; 13(18):4302-10. PMC: 395357. DOI: 10.1002/j.1460-2075.1994.tb06750.x. View

12.

Pagano M, Tam S, Theodoras A, Del Sal G, Chau V, Yew P . Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 1995; 269(5224):682-5. DOI: 10.1126/science.7624798. View

13.

Galaktionov K, Lee A, Eckstein J, Draetta G, Meckler J, Loda M . CDC25 phosphatases as potential human oncogenes. Science. 1995; 269(5230):1575-7. DOI: 10.1126/science.7667636. View

14.

Lees E . Cyclin dependent kinase regulation. Curr Opin Cell Biol. 1995; 7(6):773-80. DOI: 10.1016/0955-0674(95)80060-3. View

15.

Cady B, Stone M, Schuler J, Thakur R, Wanner M, Lavin P . The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg. 1996; 131(3):301-8. DOI: 10.1001/archsurg.1996.01430150079015. View

16.

Magi-Galluzzi C, Mishra R, Fiorentino M, Montironi R, Yao H, Capodieci P . Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. Lab Invest. 1997; 76(1):37-51. View

17.

Tan P, Cady B, Wanner M, Worland P, Cukor B, Magi-Galluzzi C . The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res. 1997; 57(7):1259-63. View

18.

DelSal G, Loda M, Pagano M . Cell cycle and cancer: critical events at the G1 restriction point. Crit Rev Oncog. 1996; 7(1-2):127-42. DOI: 10.1615/critrevoncog.v7.i1-2.80. View

19.

Draetta G, Eckstein J . Cdc25 protein phosphatases in cell proliferation. Biochim Biophys Acta. 1997; 1332(2):M53-63. DOI: 10.1016/s0304-419x(96)00049-2. View

20.

Dettmar P, Harbeck N, Thomssen C, Pache L, Ziffer P, Fizi K . Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer. Br J Cancer. 1997; 75(10):1525-33. PMC: 2223494. DOI: 10.1038/bjc.1997.261. View